ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.
Department of Medical Oncology, National Cancer Centre, Singapore.
Mabel
M
Wong
Ana Richelia
AR
Jara-Lazaro
Raymond Chee
RC
Hui Ng
Alvin Soon
AS
Tiong Lim
Poh Yian
PY
Cheok
Tse-Hui
TH
Lim
Puay Hoon
PH
Tan
Nan Soon
NS
Wong
D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000601:surgery / Q000628:therapy*; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology* / Q000601:surgery / Q000628:therapy*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008565:Membrane Proteins / Q000235:genetics; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000473:pathology*; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics*; D000097764:ETS Translocation Variant 6 Protein
D014408:Biomarkers, Tumor; D008565:Membrane Proteins; D050783:Proto-Oncogene Proteins c-ets; D012097:Repressor Proteins; D000097764:ETS Translocation Variant 6 Protein; C081876:CKAP4 protein, human